279 related articles for article (PubMed ID: 9479010)
1. Cellular regulation of islet hormone secretion by the incretin hormone glucagon-like peptide 1.
Gromada J; Holst JJ; Rorsman P
Pflugers Arch; 1998 Apr; 435(5):583-94. PubMed ID: 9479010
[TBL] [Abstract][Full Text] [Related]
2. Glucagon-like peptide-1: regulation of insulin secretion and therapeutic potential.
Gromada J; Brock B; Schmitz O; Rorsman P
Basic Clin Pharmacol Toxicol; 2004 Dec; 95(6):252-62. PubMed ID: 15569269
[TBL] [Abstract][Full Text] [Related]
3. New insights into the regulation of glucagon secretion by glucagon-like peptide-1.
Gromada J; Rorsman P
Horm Metab Res; 2004; 36(11-12):822-9. PubMed ID: 15655714
[TBL] [Abstract][Full Text] [Related]
4. Glucagon-like peptide-I and the control of insulin secretion in the normal state and in NIDDM.
Thorens B; Waeber G
Diabetes; 1993 Sep; 42(9):1219-25. PubMed ID: 8349031
[TBL] [Abstract][Full Text] [Related]
5. Glucagon-like peptide-1 structure, function and potential use for NIDDM.
Gefel D; Barg Y; Zimlichman R
Isr J Med Sci; 1997 Oct; 33(10):690-5. PubMed ID: 9397146
[TBL] [Abstract][Full Text] [Related]
6. New insights concerning the glucose-dependent insulin secretagogue action of glucagon-like peptide-1 in pancreatic beta-cells.
Holz GG
Horm Metab Res; 2004; 36(11-12):787-94. PubMed ID: 15655710
[TBL] [Abstract][Full Text] [Related]
7. Glucagon-like peptide-1 (GLP-1): a gut hormone of potential interest in the treatment of diabetes.
Ahrén B
Bioessays; 1998 Aug; 20(8):642-51. PubMed ID: 9780839
[TBL] [Abstract][Full Text] [Related]
8. cAMP-dependent mobilization of intracellular Ca2+ stores by activation of ryanodine receptors in pancreatic beta-cells. A Ca2+ signaling system stimulated by the insulinotropic hormone glucagon-like peptide-1-(7-37).
Holz GG; Leech CA; Heller RS; Castonguay M; Habener JF
J Biol Chem; 1999 May; 274(20):14147-56. PubMed ID: 10318832
[TBL] [Abstract][Full Text] [Related]
9. [GIP and GLP-1: multiplicity of regulator mechanisms for insulin secretion].
Thorens B
Journ Annu Diabetol Hotel Dieu; 2004; ():111-25. PubMed ID: 15259310
[No Abstract] [Full Text] [Related]
10. The entero-insular axis in type 2 diabetes--incretins as therapeutic agents.
Creutzfeldt W
Exp Clin Endocrinol Diabetes; 2001; 109 Suppl 2():S288-303. PubMed ID: 11460578
[TBL] [Abstract][Full Text] [Related]
11. Multisite regulation of insulin secretion by cAMP-increasing agonists: evidence that glucagon-like peptide 1 and glucagon act via distinct receptors.
Gromada J; Ding WG; Barg S; Renström E; Rorsman P
Pflugers Arch; 1997 Sep; 434(5):515-24. PubMed ID: 9242714
[TBL] [Abstract][Full Text] [Related]
12. The recombinant rat glucagon-like peptide-1 receptor, expressed in an alpha-cell line, is coupled to adenylyl cyclase activation and intracellular calcium release.
Dillon JS; Lu M; Bowen S; Homan LL
Exp Clin Endocrinol Diabetes; 2005 Mar; 113(3):182-9. PubMed ID: 15789279
[TBL] [Abstract][Full Text] [Related]
13. Glucagon-like peptides: regulators of cell proliferation, differentiation, and apoptosis.
Drucker DJ
Mol Endocrinol; 2003 Feb; 17(2):161-71. PubMed ID: 12554744
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic potential of glucagon-like peptide 1 in type 2 diabetes.
Nauck M
Diabet Med; 1996 Sep; 13(9 Suppl 5):S39-43. PubMed ID: 8894470
[TBL] [Abstract][Full Text] [Related]
15. Glucagon-like peptide 1: evolution of an incretin into a treatment for diabetes.
D'Alessio DA; Vahl TP
Am J Physiol Endocrinol Metab; 2004 Jun; 286(6):E882-90. PubMed ID: 15140755
[TBL] [Abstract][Full Text] [Related]
16. Human studies with glucagon-like-peptide-1: potential of the gut hormone for clinical use.
Byrne MM; Göke B
Diabet Med; 1996 Oct; 13(10):854-60. PubMed ID: 8911778
[TBL] [Abstract][Full Text] [Related]
17. Signal transduction of PACAP and GLP-1 in pancreatic beta cells.
Leech CA; Holz GG; Habener JF
Ann N Y Acad Sci; 1996 Dec; 805():81-92; discussion 92-3. PubMed ID: 8993395
[TBL] [Abstract][Full Text] [Related]
18. Glucagon-like peptide-1(7-37)/(7-36)amide is a new incretin.
Fehmann HC; Göke R; Göke B
Mol Cell Endocrinol; 1992 May; 85(1-2):C39-44. PubMed ID: 1382025
[TBL] [Abstract][Full Text] [Related]
19. GLP-1 in NIDDM.
Holst JJ
Diabet Med; 1996 Sep; 13(9 Suppl 6):S156-60. PubMed ID: 8894501
[TBL] [Abstract][Full Text] [Related]
20. Glucagon-like peptide-1-(7-36)amide and a rise in cyclic adenosine 3',5'-monophosphate increase cytosolic free Ca2+ in rat pancreatic beta-cells by enhancing Ca2+ channel activity.
Yada T; Itoh K; Nakata M
Endocrinology; 1993 Oct; 133(4):1685-92. PubMed ID: 8404610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]